Brainsway Surges Most in Five Years on Depression Trial Results

Brainsway Ltd. (BRIN) surged the most in more than five years after the maker of devices to treat neurological disorders said trial results of its Deep TMS treatment showed a significant drop in depression.

The shares gained 37 percent, the biggest intraday jump since January 2007 when Bloomberg started tracking the data, to 27.65 shekels at 11:09 a.m. in Tel Aviv.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.